Study shows Favipiravir provides multiple benefits in COVID-19 treatment: Glenmark Pharmaceuticals

Study shows Favipiravir provides multiple benefits in COVID-19 treatment: Glenmark Pharmaceuticals Favipiravir is an antiviral medication that works by inhibiting a viral enzyme called RdRP (RNA dependent RNA polymerase), thereby halting the virus’s replication cycle. This helps control the multiplication of the virus and prevents its spread in the patient, Glenmark said.

No comments:

Post a Comment